Medicare Enrolled

Dr. Yunfei Wei, MD

Hematology & Oncology · Downey, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
11480 BROOKSHIRE AVE, Downey, CA 90241
5628691201
In practice since 2007 (18 years)
NPI: 1801075684 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wei from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wei? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wei

Dr. Yunfei Wei is a hematology & oncology specialist in Downey, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Wei performed 898 Medicare services across 341 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wei received a total of $8,956 from 61 pharmaceutical and/or device companies across 378 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wei is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 898 Medicare services $8,956 industry payments

Medicare Practice Summary

Medicare Utilization ↗
898
Medicare services
Bottom 48% in CA for hematology & oncology
341
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~50 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
664 $99 $150
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
105 $145 $276
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
56 $101 $185
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
53 $96 $200
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
20 $154 $260
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,956
Total received (2018-2024)
Avg $1,279/year across 7 years
Top 34% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
378
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,184 (91.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$772 (8.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$619
2023
$204
2022
$98
2021
$265
2020
$1,955
2019
$4,022
2018
$1,794

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$115
ABBVIE INC.
$80
Alexion Pharmaceuticals, Inc.
$50
PFIZER INC.
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
Janssen Biotech, Inc.
$35
BeiGene USA, Inc.
$35
Regeneron Healthcare Solutions, Inc.
$33
GlaxoSmithKline, LLC.
$29
Gilead Sciences, Inc.
$28
PUMA BIOTECHNOLOGY, INC.
$28
Daiichi Sankyo Inc.
$23
Genentech USA, Inc.
$21
Merck Sharp & Dohme LLC
$19
Novartis Pharmaceuticals Corporation
$15
Astellas Pharma US Inc
$14
E.R. Squibb & Sons, L.L.C.
$13
Top 3 companies account for 39.6% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$682
Novartis Pharmaceuticals Corporation
$581
Alexion Pharmaceuticals, Inc.
$521
Celgene Corporation
$504
Amgen Inc.
$425
Takeda Pharmaceuticals U.S.A., Inc.
$419
Genentech USA, Inc.
$360
Merck Sharp & Dohme Corporation
$347
E.R. Squibb & Sons, L.L.C.
$308
Lilly USA, LLC
$307
Astellas Pharma US Inc
$306
Bayer HealthCare Pharmaceuticals Inc.
$290
Seattle Genetics, Inc.
$279
AbbVie, Inc.
$276
AstraZeneca Pharmaceuticals LP
$263
EISAI INC.
$226
Foundation Medicine, Inc.
$176
Janssen Biotech, Inc.
$167
Boehringer Ingelheim Pharmaceuticals, Inc.
$166
Clovis Oncology, Inc.
$162
Puma Biotechnology, Inc.
$155
Pharmacyclics LLC, An AbbVie Company
$138
Daiichi Sankyo Inc.
$127
Eisai Inc.
$127
TESARO, Inc.
$114
Incyte Corporation
$108
EMD Serono, Inc.
$102
Gilead Sciences, Inc.
$85
Emmaus Medical, Inc.
$84
ABBVIE INC.
$80
BeiGene USA, Inc.
$75
GlaxoSmithKline, LLC.
$75
Rigel Pharmaceuticals, Inc.
$66
Secura Bio, Inc.
$58
AbbVie Inc.
$58
Seagen Inc.
$50
Exelixis Inc.
$45
Dova Pharmaceuticals
$44
Teva Pharmaceuticals USA, Inc.
$43
Verastem, Inc.
$40
Spectrum Pharmaceuticals Inc.
$39
Myriad Genetic Laboratories, Inc.
$35
Regeneron Healthcare Solutions, Inc.
$33
Dendreon Pharmaceuticals LLC
$33
Karyopharm Therapeutics Inc.
$31
Janssen Scientific Affairs, LLC
$29
TerSera Therapeutics LLC
$29
GENZYME CORPORATION
$28
PUMA BIOTECHNOLOGY, INC.
$28
AMAG Pharmaceuticals, Inc.
$25
Aurobindo Pharma USA, Inc.
$24
Global Blood Therapeutics, Inc.
$24
Shire North American Group Inc
$22
INSYS Therapeutics Inc
$19
Merck Sharp & Dohme LLC
$19
SANOFI-AVENTIS U.S. LLC
$18
Partner Therapeutics, Inc.
$17
Ipsen Biopharmaceuticals, Inc
$17
Otsuka America Pharmaceutical, Inc.
$16
Advanced Accelerator Applications
$15
Blueprint Medicines Corporation
$14
Top 3 companies account for 19.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Abraxane · Alecensa · BAVENCIO · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELAHERE · EMPLICITI · EPKINLY · ERBITUX · Endari · Enhertu · FARYDAK · FERAHEME · FOUNDATIONONE · FOUNDATIONONE CDX · Farydak · Folotyn · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · Leukine · MEKINIST · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · OPDIVO · OPDUALAG · OXBRYTA · PADCEV · PROMACTA · PROVENGE · Padcev · Perjeta · Polivy · Pomalyst · RYBREVANT · Revlimid · Rubraca · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TEVIMBRA · TUKYSA · Tavalisse · ULTOMIRIS · VENCLEXTA · VOTRIENT · Venclexta · XALKORI · XGEVA · XPOVIO · XTANDI · Xofigo · Xtandi · ZEJULA · ZOLADEX · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Downey?
Compare hematology & oncology specialists in the Downey area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
452
Per 100K population
4.6
County median income
$87,760
Nearest hospital
PIH HEALTH DOWNEY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wei is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wei experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Wei performed 664 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wei receive payments from pharmaceutical companies?
Yes. Dr. Wei received a total of $8,956 from 61 companies across 378 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wei's costs compare to other hematology & oncology specialists in Downey?
Dr. Wei's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wei) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →